Torento 90
Description
đ Terento 90 â Etoricoxib 90 mg Tablet
Manufacturer: SinoHealth Pharmaceuticals LTD
1. Indications:
Torento 90 is indicated for the symptomatic relief of:
-
Osteoarthritis (OA)
-
Rheumatoid Arthritis (RA)
-
Ankylosing Spondylitis
-
Pain and inflammation associated with acute gouty arthritis
-
Short-term treatment of moderate pain after dental surgery
āϰā§āĻāĻŋāϏā§āĻāĻžāϰā§āĻĄ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻŽā§āϤāĻžāĻŦā§āĻ āĻāώāϧ āϏā§āĻŦāύ āĻāϰā§āύāĨ¤
2. Pharmacology:
Etoricoxib is a potent, orally active, COX-2 selective inhibitor.
There are two forms of cyclooxygenase:
-
COX-1: Responsible for normal physiological functions such as gastric protection and platelet aggregation.
-
COX-2: Mainly responsible for the synthesis of prostaglandins that cause pain, inflammation, and fever.
By selectively inhibiting COX-2, Etoricoxib relieves pain and inflammation without affecting COX-1, reducing the risk of gastric damage and bleeding.
At doses up to 90 mg daily, Etoricoxib inhibits COX-2 without inhibiting gastric prostaglandin synthesis.
3. Dosage & Administration:
Adults and adolescents (16 years and older):
-
Osteoarthritis: 30 mg once daily (may increase to 60 mg if needed).
-
Rheumatoid Arthritis: 90 mg once daily.
-
Ankylosing Spondylitis: 90 mg once daily.
-
Acute Gouty Arthritis: 90 mg once daily (short-term as per physician).
-
Postoperative Dental Pain: 90 mg once daily (up to 3 days).
â ī¸ Use the lowest effective dose for the shortest possible duration.
Reassess the patientâs need for continued therapy periodically.
āϰā§āĻāĻŋāϏā§āĻāĻžāϰā§āĻĄ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻŽā§āϤāĻžāĻŦā§āĻ āĻāώāϧ āϏā§āĻŦāύ āĻāϰā§āύāĨ¤
4. Drug Interactions:
With Medicines:
-
Warfarin: May increase prothrombin time.
-
Diuretics, ACE inhibitors, Angiotensin II antagonists: May reduce antihypertensive effects.
-
Low-dose Aspirin: Can be used together for cardiovascular prophylaxis.
-
Ciclosporin or Tacrolimus: May increase nephrotoxicity risk.
-
Lithium: May increase lithium levels by reducing renal excretion.
With Food:
-
Can be taken with or without food.
5. Contraindications:
-
Hypersensitivity to Etoricoxib or any excipients
-
Active peptic ulcer or gastrointestinal bleeding
-
History of asthma, urticaria, or allergic reactions to NSAIDs or aspirin
-
Pregnancy and lactation
-
Severe hepatic impairment (Child-Pugh âĨ10 or serum albumin <25 g/L)
-
Renal impairment (CrCl <30 mL/min)
-
Children under 16 years
-
Inflammatory bowel disease
-
Congestive heart failure (NYHA IIâIV)
-
Uncontrolled hypertension (âĨ140/90 mmHg)
-
Established ischemic heart disease, peripheral arterial disease, or cerebrovascular disease
6. Side Effects:
-
Common: Palpitation, fatigue, influenza-like symptoms, dizziness
-
Less common: Dry mouth, taste disturbance, appetite change, atrial fibrillation, cough, dyspnoea, anxiety
-
Rare: Confusion, hallucinations, weight change, mouth ulcer, paraesthesia, muscle/joint pain
7. Pregnancy & Lactation:
-
Not recommended for women attempting to conceive.
-
Contraindicated during pregnancy and lactation.
-
Excreted in rat milk; human excretion unknown.
8. Precautions & Warnings:
-
Use cautiously in elderly patients and those with a history of ulcers or GI bleeding.
-
Monitor patients with cardiovascular risk factors (hypertension, diabetes, smoking).
-
Monitor renal function in patients with dehydration, renal impairment, or heart failure.
-
Discontinue if liver dysfunction or abnormal LFTs occur.
-
Stop treatment if skin rash or hypersensitivity appears.
-
May mask fever or signs of infection.
-
Caution when co-administered with warfarin or anticoagulants.
9. Overdose Effects:
-
Single doses up to 500 mg or multiple doses up to 150 mg/day show no major toxicity.
-
In overdose: apply supportive measures â gastric lavage, monitoring, and symptomatic care.
10. Therapeutic Class:
Non-Steroidal Anti-Inflammatory Drug (NSAID) â COX-2 Selective Inhibitor
11. Storage Conditions:
-
Store below 30°C, protected from light and moisture.
-
Keep all medicines out of the reach of children.




